This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Jeonnam Bioindustry Foundation. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Kyo Nyeo Oh: Innovator in Pharmaceutical Composition
Introduction
Kyo Nyeo Oh is a notable inventor based in Gwangju, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating stress-related diseases and depression. His innovative approach utilizes natural resources, showcasing the potential of local flora in medical applications.
Latest Patents
Kyo Nyeo Oh holds a patent for a pharmaceutical composition containing an extract of leaves of Thunb. This invention is designed for the prevention or treatment of stress diseases and depression. The composition is notable for its safety, as it can be used without toxicity and side effects. By leveraging a natural resource indigenous to Korea, this invention not only aims to improve health outcomes but also seeks to reduce manufacturing costs and promote local production.
Career Highlights
Kyo Nyeo Oh is affiliated with the Jeonnam Bioindustry Foundation, where he continues to advance his research and development efforts. His work is characterized by a commitment to harnessing natural ingredients for therapeutic purposes, reflecting a growing trend in the pharmaceutical industry towards more sustainable and eco-friendly practices.
Collaborations
Kyo Nyeo Oh collaborates with esteemed colleagues such as Chul Yung Choi and Dool Ri Oh. Their combined expertise enhances the research and development process, fostering innovation in the field of pharmaceuticals.
Conclusion
Kyo Nyeo Oh exemplifies the spirit of innovation in the pharmaceutical industry through his work on natural compositions for mental health. His contributions not only address critical health issues but also promote the use of local resources, paving the way for future advancements in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile